Kiniksa Pharmaceuticals Ltd. Class A Aktie News
37,03 $
2,27 %
heute
Nasdaq,
13. Oktober, 22:00 Uhr
tracken
Kiniksa Pharmaceuticals Ltd. Class A Aktie News
Neutral
Seeking Alpha
●
etwa ein Monat alt
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA ) Citi's Biopharma Back to School Conference September 3, 2025 9:00 AM EDT Company Participants Sanj Patel - CEO & Chairman of the Board Ross Moat - Executive VP & Chief Commercial Officer John Paolini - Executive VP & Chief Medical Officer Conference Call Participants Geoffrey Meacham - Citigroup Inc., Research Division Presentation Geoff...
Neutral
GlobeNewsWire
●
etwa 2 Monate alt
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in September:
Neutral
Investors Business Daily
●
2 Monate alt
A good medical stock can help diversify a portfolio. This particular name is testing a fresh entry as funds pile in.
Neutral
Seeking Alpha
●
3 Monate alt
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA ) Q2 2025 Earnings Call July 29, 2025 8:30 AM ET Company Participants Jonathan Kirshenbaum - Investor Relations Officer Mark A. Ragosa - Senior VP & CFO Ross Michael Moat - Executive VP & Chief Commercial Officer Sanj K.
Neutral
GlobeNewsWire
●
3 Monate alt
Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution
– ARCALYST ® (rilonacept) Q2 2025 net product revenue of $156.8 million, representing 52% year-over-year growth – – ARCALYST 2025 expected net product revenue increased to $625 - $640 million – – KPL-387 Phase 2/3 clinical trial in recurrent pericarditis initiated; Phase 2 data expected in 2H 2026 – – Cash balance increased by $39.4 million in Q2 2025 to $307.8 million – – Conference call and w...
Neutral
GlobeNewsWire
●
3 Monate alt
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution.
Positiv
The Motley Fool
●
3 Monate alt
Explore the exciting world of Kiniksa Pharmaceuticals (KNSA 0.99%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Positiv
Investors Business Daily
●
3 Monate alt
Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
